EC Psychology and Psychiatry

The aim of this study is to provide a comprehensive overview of spatial multiomics analysis, including its definition, processes, applications, significance and relevant research in psychiatric disorders. To achieve this, a literature search was conducted, focusing on three major spatial omics techniques and their application to three common psychiatric disorders: Alzheimer’s disease (AD), schizophrenia, and autism spectrum disorders. Spatial genomics analysis has revealed specific genes associated with neuropsychiatric disorders in certain brain regions. Spatial transcriptomics analysis has identified genes related to AD in areas such as the hippocampus, olfactory bulb, and middle temporal gyrus. It has also provided insight into the response to AD in mouse models. Spatial proteogenomics has identified autism spectrum disorder (ASD)-risk genes in specific cell types, while schizophrenia risk loci have been linked to transcriptional signatures in the human hippocampus. In summary, spatial multiomics analysis offers a powerful approach to understand AD pathology and other psychiatric diseases, integrating multiple data modalities to identify risk genes for these disorders. It is valuable for studying psychiatric disorders with high or low cellular heterogeneity and provides new insights into the brain nucleome to predict disease progression and aid diagnosis and treatment.

Keywords: Spatial Genomics; Spatial Transcriptomics; Spatial Proteogenomics; Alzheimer’s Disease; Schizophrenia; Autism Spectrum Disorder

1. Ya D., et al. “Application of spatial transcriptome technologies to neurological diseases”. Frontiers in Cell and Developmental Biology 11 (2023): 1142923.
2. Fujita Y., et al. “3D spatial genome organization in the nervous system: From development and plasticity to disease”. Neuron18 (2022): 2902-2915.
3. Navarro JF., et al. “Spatial Transcriptomics Reveals Genes Associated with Dysregulated Mitochondrial Functions and Stress Signaling in Alzheimer Disease”. iScience10 (2020): 101556.
4. Chen WT., et al. “Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer's Disease”. Cell4 (2020): 976-991 e919.
5. Jiang X., et al. “Principles of connectivity among morphologically defined cell types in adult neocortex”. Science6264 (2015): aac9462.
6. Kita Y., et al. “Cellular-resolution gene expression profiling in the neonatal marmoset brain reveals dynamic species- and region-specific differences”. Proceedings of the National Academy of Sciences of the United States of America18 (2021).
7. Maynard KR., et al. “Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex”. Nature Neuroscience3 (2021): 425-436.
8. Doostparast Torshizi A and Wang K. “Tissue-wide cell-specific proteogenomic modeling reveals novel candidate risk genes in autism spectrum disorders”. NP Journal Systems Biology and Applications1 (2022): 31.
9. Rajarajan P., et al. “Spatial genome exploration in the context of cognitive and neurological disease”. Current Opinion in Neurobiology 59 (2019): 112-119.
10. Chen S., et al. “Spatially resolved transcriptomics reveals genes associated with the vulnerability of middle temporal gyrus in Alzheimer's disease”. Acta Neuropathologica Communications1 (2022): 188.
11. Jaffe AE., et al. “Profiling gene expression in the human dentate gyrus granule cell layer reveals insights into schizophrenia and its genetic risk”. Nature Neuroscience4 (2020): 510-519.